Supplementary Figure S1 from HLA class II loss and JAK1/2 deficiency coevolve in melanoma leading to CD4 T cell and IFNγ cross-resistance

DOI: 10.1158/1078-0432.27031804.v1 Publication Date: 2024-09-16T12:26:44Z